10-Q: America Great Health Reports Increased Sales but Continues to Face Going Concern Challenges in Q1 2025

America Great Health's Q1 2025 shows increased sales due to new product launches, but the company still faces a significant shareholders' deficit and going concern uncertainties.

Summary

• America Great Health's Q1 2025 report reveals increased sales, reaching $140,126 compared to $13,808 in Q1 2024, primarily due to the introduction of new products.
• The cost of goods sold also increased to $11,335 from $177 in the same period last year, aligning with the new product launches.
• Gross profit rose to $128,791 from $13,631 year-over-year.
• Operating expenses increased to $199,650 from $88,569, driven by higher advertising and professional expenses.
• The net loss decreased to $146,967 from $156,980, attributed to reduced payroll and professional expenses.
• The company's liquidity remains a concern, with a shareholders' deficit of $5,389,271 and a net cash used in operating activities of $95,578.
• As of September 30, 2024, the company had a cash balance of $49,031.
• The company's ability to continue as a going concern is dependent on securing additional capital and achieving profitable operations.
• The company had federal and California income tax net operating loss carryforwards of approximately $8 million as of September 30, 2024.
• Subsequent to the quarter, on December 30, 2024, the company issued 5,200,000 shares for $68,000, 6,800,000 shares as a gift to a consultant, and 1,823,282 shares for $9,116.
• On February 24, 2025, the company received $25,000 for 100,000 shares, which have not yet been issued.

Sentiment

Score: 4

Explanation: The sentiment is cautiously negative due to increased sales being overshadowed by significant financial challenges, including a substantial shareholders' deficit and going concern uncertainties. While there are positive signs of growth, the overall financial health raises concerns.

Positives

• Sales increased significantly due to the launch of new products, indicating market interest and potential for growth.
• Gross profit improved substantially, reflecting better revenue generation relative to the cost of goods sold.
• The net loss decreased slightly, suggesting some improvement in overall financial performance.
• The company has significant net operating loss carryforwards that can be used to offset future taxable income.

Negatives

• The company has a substantial shareholders' deficit, indicating significant accumulated losses.
• The company's cash balance is low, raising concerns about its ability to meet short-term obligations.
• Operating expenses increased significantly, offsetting some of the gains from increased sales.
• The company's auditors have raised substantial doubt about its ability to continue as a going concern.

Risks

• The company's ability to continue as a going concern is uncertain and depends on securing additional capital and achieving profitable operations.
• The company's low cash balance poses a risk to its ability to meet short-term obligations.
• Increased operating expenses could hinder the company's ability to achieve profitability.
• The company's reliance on loans and advances from its majority shareholder creates a dependency risk.
• The company's internal controls are identified as ineffective, which could lead to financial misstatements.

Future Outlook

The company's future plans revolve around achieving profitable operations and raising necessary capital to cover ongoing expenses; the ability to continue as a going concern is dependent on these factors.

Management Comments

• Management believes that the material weaknesses set forth in above did not have an effect on our financial results.
• Management believes that the lack of a functioning audit committee and the lack of a majority of outside directors on our board of directors results in ineffective oversight in the establishment and monitoring of required internal controls and procedures, which could result in a material misstatement in our financial statements in future periods.

Industry Context

The company operates in the healthcare ecosystem, focusing on innovative technologies, protein and peptide small molecular drugs, diagnostic and medical devices with AI cloud computing, cell therapy and regenerational medicine, and supplements manufacturing and sales; this positions them in a competitive but potentially high-growth market.

Comparison to Industry Standards

• It is difficult to compare America Great Health's performance to industry standards without knowing the specific sub-sectors in which it operates and the size of comparable companies.
• However, the company's significant increase in sales suggests potential for growth, but its negative equity and cash flow issues are concerning compared to more established industry players.
• For example, larger pharmaceutical companies like Pfizer or Johnson & Johnson have robust balance sheets and consistent profitability, which America Great Health currently lacks.
• Similarly, established medical device companies like Medtronic or Stryker have strong cash flows and well-defined market positions, contrasting with America Great Health's early-stage development.

Related Party Transactions

• During the three months ended September 30, 2024, the company's current majority shareholder advanced $133,794 to the company as working capital, and the company repaid $153,710 to the shareholder.
• As of September 30, 2024, the company owed its current majority shareholder $1,090,280.

Stakeholder Impact

• Shareholders face significant risk due to the company's going concern uncertainties and substantial shareholders' deficit.
• Employees' job security is uncertain due to the company's financial instability.
• Customers may be concerned about the company's ability to fulfill orders and provide ongoing support.
• Suppliers may face increased risk of non-payment due to the company's liquidity issues.
• Creditors face higher risk of default due to the company's financial difficulties.

Next Steps

• The company needs to secure additional capital to address its liquidity concerns and continue operations.
• The company must focus on achieving profitable operations to improve its financial stability.
• The company should address the identified material weaknesses in its internal controls to ensure accurate financial reporting.

Key Dates

Keywords

financial statements, going concern, net loss, sales, liquidity, healthcare, America Great Health